Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Recovering Gene Interactions from Single-Cell Data Using Data Diffusion.

van Dijk D, Sharma R, Nainys J, Yim K, Kathail P, Carr AJ, Burdziak C, Moon KR, Chaffer CL, Pattabiraman D, Bierie B, Mazutis L, Wolf G, Krishnaswamy S, Pe'er D.

Cell. 2018 Jul 26;174(3):716-729.e27. doi: 10.1016/j.cell.2018.05.061. Epub 2018 Jun 28.

2.

The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy.

Krall JA, Reinhardt F, Mercury OA, Pattabiraman DR, Brooks MW, Dougan M, Lambert AW, Bierie B, Ploegh HL, Dougan SK, Weinberg RA.

Sci Transl Med. 2018 Apr 11;10(436). pii: eaan3464. doi: 10.1126/scitranslmed.aan3464.

3.

Meiotic recombination modulates the structure and dynamics of the synaptonemal complex during C. elegans meiosis.

Pattabiraman D, Roelens B, Woglar A, Villeneuve AM.

PLoS Genet. 2017 Mar 24;13(3):e1006670. doi: 10.1371/journal.pgen.1006670. eCollection 2017 Mar.

4.

Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.

Bierie B, Pierce SE, Kroeger C, Stover DG, Pattabiraman DR, Thiru P, Liu Donaher J, Reinhardt F, Chaffer CL, Keckesova Z, Weinberg RA.

Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2337-E2346. doi: 10.1073/pnas.1618298114. Epub 2017 Mar 7.

5.

Emerging Biological Principles of Metastasis.

Lambert AW, Pattabiraman DR, Weinberg RA.

Cell. 2017 Feb 9;168(4):670-691. doi: 10.1016/j.cell.2016.11.037. Review.

6.

Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy.

Pattabiraman DR, Weinberg RA.

Cold Spring Harb Symp Quant Biol. 2016;81:11-19. doi: 10.1101/sqb.2016.81.030957. Epub 2017 Jan 5. Review.

7.

Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability.

Pattabiraman DR, Bierie B, Kober KI, Thiru P, Krall JA, Zill C, Reinhardt F, Tam WL, Weinberg RA.

Science. 2016 Mar 4;351(6277):aad3680. doi: 10.1126/science.aad3680.

8.

Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML.

Forristal CE, Brown AL, Helwani FM, Winkler IG, Nowlan B, Barbier V, Powell RJ, Engler GA, Diakiw SM, Zannettino AC, Martin S, Pattabiraman D, D'Andrea RJ, Lewis ID, Levesque JP.

Leukemia. 2015 Oct;29(10):2075-85. doi: 10.1038/leu.2015.102. Epub 2015 Apr 29.

PMID:
25921247
9.

DNA helicase HIM-6/BLM both promotes MutSγ-dependent crossovers and antagonizes MutSγ-independent interhomolog associations during caenorhabditis elegans meiosis.

Schvarzstein M, Pattabiraman D, Libuda DE, Ramadugu A, Tam A, Martinez-Perez E, Roelens B, Zawadzki KA, Yokoo R, Rosu S, Severson AF, Meyer BJ, Nabeshima K, Villeneuve AM.

Genetics. 2014 Sep;198(1):193-207. doi: 10.1534/genetics.114.161513. Epub 2014 Jul 21.

10.

Tackling the cancer stem cells - what challenges do they pose?

Pattabiraman DR, Weinberg RA.

Nat Rev Drug Discov. 2014 Jul;13(7):497-512. doi: 10.1038/nrd4253. Review.

11.

Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.

Pattabiraman DR, McGirr C, Shakhbazov K, Barbier V, Krishnan K, Mukhopadhyay P, Hawthorne P, Trezise A, Ding J, Grimmond SM, Papathanasiou P, Alexander WS, Perkins AC, Levesque JP, Winkler IG, Gonda TJ.

Blood. 2014 Apr 24;123(17):2682-90. doi: 10.1182/blood-2012-02-413187. Epub 2014 Mar 4.

PMID:
24596419
12.

miR-139-5p is a regulator of metastatic pathways in breast cancer.

Krishnan K, Steptoe AL, Martin HC, Pattabiraman DR, Nones K, Waddell N, Mariasegaram M, Simpson PT, Lakhani SR, Vlassov A, Grimmond SM, Cloonan N.

RNA. 2013 Dec;19(12):1767-80. doi: 10.1261/rna.042143.113. Epub 2013 Oct 24.

13.

Meiotic HORMA domain proteins prevent untimely centriole disengagement during Caenorhabditis elegans spermatocyte meiosis.

Schvarzstein M, Pattabiraman D, Bembenek JN, Villeneuve AM.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):E898-907. doi: 10.1073/pnas.1213888110. Epub 2013 Feb 11.

14.

Role and potential for therapeutic targeting of MYB in leukemia.

Pattabiraman DR, Gonda TJ.

Leukemia. 2013 Feb;27(2):269-77. doi: 10.1038/leu.2012.225. Epub 2012 Aug 9. Review.

PMID:
22874877
15.

LIN-44/Wnt directs dendrite outgrowth through LIN-17/Frizzled in C. elegans Neurons.

Kirszenblat L, Pattabiraman D, Hilliard MA.

PLoS Biol. 2011 Sep;9(9):e1001157. doi: 10.1371/journal.pbio.1001157. Epub 2011 Sep 20.

16.

Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb.

Zhao L, Glazov EA, Pattabiraman DR, Al-Owaidi F, Zhang P, Brown MA, Leo PJ, Gonda TJ.

Nucleic Acids Res. 2011 Jun;39(11):4664-79. doi: 10.1093/nar/gkr024. Epub 2011 Feb 11.

17.

A functional SUMO-interacting motif in the transactivation domain of c-Myb regulates its myeloid transforming ability.

Saether T, Pattabiraman DR, Alm-Kristiansen AH, Vogt-Kielland LT, Gonda TJ, Gabrielsen OS.

Oncogene. 2011 Jan 13;30(2):212-22. doi: 10.1038/onc.2010.397. Epub 2010 Aug 30.

PMID:
20802522
18.

A recessive screen for genes regulating hematopoietic stem cells.

Papathanasiou P, Tunningley R, Pattabiraman DR, Ye P, Gonda TJ, Whittle B, Hamilton AE, Cridland SO, Lourie R, Perkins AC.

Blood. 2010 Dec 23;116(26):5849-58. doi: 10.1182/blood-2010-04-269951. Epub 2010 Jul 7.

PMID:
20610815
19.

Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.

Pattabiraman DR, Sun J, Dowhan DH, Ishii S, Gonda TJ.

Mol Cancer Res. 2009 Sep;7(9):1477-86. doi: 10.1158/1541-7786.MCR-09-0070. Epub 2009 Sep 8.

Supplemental Content

Loading ...
Support Center